Newsletter | June 18, 2020

06.18.20 -- 5 Critical Considerations On Your Path To Commercial Biologics Manufacturing

You Are Never Too Small To Think Big!

Your automation platform can be designed to expand with your business if you consider your design choices in the initial stages. Early platform design choices can greatly affect your speed-to-market and ability to show compliance throughout regulatory reviews.

The Economics Of Biomanufacturing Strategies: Can You Afford Failure?

Prior to making critical strategy decisions, a small biotech company completed an economic evaluation of manufacturing options to ensure it was selecting the best fit for its drug development needs. Discover the critical elements of this analysis that may help to balance your expansion outlook.

The Evolution Of Supply Chain Security — Increased Focus On Raw Material Variability

Qualifying two suppliers, increasing capacity, implementing a scorecard methodology for strategic suppliers, and surveying suppliers for their number of production lines are all important ways to guarantee steady supply of materials and technologies — but close attention must also be paid to raw materials.

Best Practices For A Successful Bioprocess Technology Transfer

Technology transfer is a formalized process for moving the manufacture of a drug from one facility, one scale, or one drug life cycle phase to another. A well-executed bioprocess technology transfer is critical to ensure smooth knowledge transfer and optimal process reproducibility. 

Bridging The Skills Gap In Biopharma

Your employees must have the skills necessary to effectively execute on process development and manufacturing operations. How can you ensure they are up to date on today’s complex bioprocessing techniques and technologies?

Virtual Event